 Theravance Biopharma, Inc. NASDAQ: TBPH has agreed to sell all of its units in Theravance Respiratory Company, LLC, representing 85 economic interest in the sales-based royalty rights on worldwide net sales of GSK plcs NYSE: GSK TRELEGY ELLIPTA to Royalty. 